AlphaCentric Advisors’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$167K Buy
7,161
+213
+3% +$6.67K 0.15% 168
2026
Q2
$239K Buy
6,948
+99
+1% +$2.91K 0.2% 150
2026
Q1
$212K Buy
6,849
+373
+6% +$9.18K 0.21% 139
2025
Q4
$135K Buy
+6,476
New +$120K 0.13% 185
2021
Q1
– Sell
-1,475
Closed -$247K – 221
2020
Q4
$247K Buy
+1,475
New +$262K 0.1% 55

Other funds holding TECX

AlphaCentric Advisors's TECX Position: Q3 2026 in Review

AlphaCentric Advisors increased its Tectonic Therapeutic (TECX) stake by 3.1% in Q3 2026, buying an estimated $6.67K and bringing the position to 7,161 shares worth $167K. The position accounts for 0.15% of the portfolio, ranked #168.

AlphaCentric Advisors first reported a position in TECX in Q4 2020 and has held it in 5 quarters since. The position peaked at $247K in Q4 2020. 87 funds tracked by Wall St. Rank hold TECX as of Q3 2026.

  • AlphaCentric Advisors held 7,161 shares of Tectonic Therapeutic worth $167K as of Q3 2026.
  • AlphaCentric Advisors bought 213 Tectonic Therapeutic shares in Q3 2026, an estimated $6.67K.
  • Tectonic Therapeutic made up 0.15% of AlphaCentric Advisors's portfolio in Q3 2026, its #168 holding.
  • AlphaCentric Advisors first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 5 quarters since.
  • AlphaCentric Advisors's Tectonic Therapeutic position peaked at $247K in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2026.

Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.